Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.938
-0.036 (-3.74%)
Jan 22, 2025, 4:00 PM EST - Market closed
Context Therapeutics Employees
Context Therapeutics had 5 employees as of December 31, 2023. The number of employees decreased by 4 or -44.44% compared to the previous year.
Employees
5
Change (1Y)
-4
Growth (1Y)
-44.44%
Revenue / Employee
n/a
Profits / Employee
-$6,030,416
Market Cap
70.33M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5 | -4 | -44.44% |
| Dec 31, 2022 | 9 | 8 | 800.00% |
| Dec 31, 2020 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
CNTX News
- 7 days ago - Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76 - GlobeNewsWire
- 9 days ago - Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors - GlobeNewsWire
- 2 months ago - Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results - GlobeNewsWire
- 3 months ago - Context Therapeutics to Participate in Upcoming Investor Conferences in November - GlobeNewsWire
- 3 months ago - Context Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting - GlobeNewsWire
- 5 months ago - Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors - GlobeNewsWire
- 6 months ago - Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results - GlobeNewsWire
- 6 months ago - Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations - GlobeNewsWire